Predictive gene signatures for bevacizumab and cetuximab as well as cytotoxic agents

Int J Clin Pharmacol Ther. 2012 Jan;50(1):70-1. doi: 10.5414/cpp50070.
No abstract available

Publication types

  • Validation Study

MeSH terms

  • Animals
  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal, Humanized / pharmacology
  • Antineoplastic Agents / pharmacology*
  • Bevacizumab
  • Cetuximab
  • Feasibility Studies
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic / drug effects*
  • Humans
  • Mice
  • Mice, Nude
  • Neoplasms / drug therapy*
  • Neoplasms / genetics
  • Xenograft Model Antitumor Assays

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Bevacizumab
  • Cetuximab